Canadian Drugstore Supports High-Risk Prostate Cancer Survival

Nov 28
08:08

2011

Remcel Mae P. Canete

Remcel Mae P. Canete

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

"In patients with locally advanced prostate cancer, combining radiation therapy plus hormonal therapy gives better results than hormone therapy alone."

mediaimage

"In patients with locally advanced prostate cancer,Canadian Drugstore Supports High-Risk Prostate Cancer Survival Articles combining radiation therapy plus hormonal therapy gives much better results than hormone therapy alone," said lead researcher Dr. Padraig Warde, deputy head of the Princess Margaret Hospital Cancer Program and a professor of radiation oncology at the University of Toronto. Plus, the aid of Canadian drugs is a great help.

"Specifically, it reduces the risk of dying from prostate cancer 43 percent and the risk of dying overall by 23 percent," he said, adding that this is the first study that shows that the combination of radiation and hormone therapy improves survival.

"These patients were often felt, in the past, to be incurable, because the disease has spread locally outside of the prostate, but not elsewhere in the body," he said. "But they shouldn't be discarded, we are showing that going for a cure is worthwhile."

"There is reason to think that with modern radiation approaches that the results would be much better," he said.  And, with various medications available, greater positive effects are expected. To buy Avodart for an instance is recommended to subside swollen prostrate.

Prostate cancer expert Dr. Anthony D'Amico, chief of radiation oncology at Brigham and Women's Hospital in Boston, said that "this doesn't change practice, because we already do this, but it's a validation that you cannot leave out one or the other treatment when treating someone with locally advanced disease."

Dr. Matthew R. Cooperberg, an assistant professor of urology at the University of California, San Francisco, and author of an accompanying journal editorial, said that "high-risk disease needs to be treated aggressively."

"However, this study doesn't determine what is the best treatment for high-risk prostate cancer," Cooperberg said. "There are studies showing that the best treatment for high-risk disease starts with surgery and then radiation and hormones as necessary," he noted.

"Men with high-risk disease need multi-modal therapy," Cooperberg said. "Whether the approach should be surgery possibly followed by radiation, is still the big open question that we need to answer."  But, one thing is for sure – Canadian pharmacy drugstores are open to serve patients who are in need of help.